<?xml version="1.0" encoding="UTF-8"?>
<ref id="B193-pathogens-09-00856">
 <label>193.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nishiyama</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Jirintai</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kii</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Nagashima</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Prathiwi Primadharsini</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nishizawa</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Okamoto</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Screening of novel drugs for inhibiting hepatitis E virus replication</article-title>
  <source>J. Virol. Methods</source>
  <year>2019</year>
  <volume>270</volume>
  <fpage>1</fpage>
  <lpage>11</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jviromet.2019.04.017</pub-id>
  <pub-id pub-id-type="pmid">31004661</pub-id>
 </element-citation>
</ref>
